Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Third Rock Ventures Ii, L.p.

Affiliations

  • Large Shareholder at Myokardia Inc (MYOK), 2018-03-07
  • Large Shareholder at Allena Pharmaceuticals Inc. (ALNA), 2017-11-06
  • Large Shareholder at Global Blood Therapeutics Inc. (GBT), 2017-06-16
  • Large Shareholder at Blueprint Medicines Corp (BPMC), 2017-02-28
  • Large Shareholder at Jounce Therapeutics Inc. (JNCE), 2017-02-03
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2016-08-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALNA $14.00 215,000 Large Shareholder 2,790,964 2017-11-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MYOK $43.00 400,000 Large Shareholder 6,885,104 2017-09-26 Filing
MYOK $43.00 201,400 Large Shareholder 7,285,104 2017-09-25 Filing
MYOK $44.25 20,000 Large Shareholder 57,651 2017-09-11 Filing
MYOK $42.39 900 Large Shareholder 7,486,504 2017-09-08 Filing
MYOK $41.00 200,350 Large Shareholder 7,487,404 2017-09-08 Filing